|
Real-time Estimate
Cboe BZX
12:00:38 29/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 6.065 USD | -1.38% |
|
-7.95% | +45.33% |
| 21/09 | Precigen Receives Fda Platform Technology Designation for Adenoverse Platform | CI |
| 21/09 | Precigen's AdenoVerse Receives FDA Platform Technology Designation | MT |
| Market Cap | 220.19Cr 197.56Cr 182.65Cr 165.42Cr 309.05Cr 21TCr 312.78Cr 2.18TCr 869.82Cr 11TCr 826.29Cr 808.85Cr 35TCr | P/E 2026 * |
28.6x | P/E 2027 * | 9.89x |
|---|---|---|---|---|---|
| Enterprise Value | 220.19Cr 197.56Cr 182.65Cr 165.42Cr 309.05Cr 21TCr 312.78Cr 2.18TCr 869.82Cr 11TCr 826.29Cr 808.85Cr 35TCr | EV / Sales 2026 * |
9.34x | EV / Sales 2027 * | 5.04x |
| Free-Float |
87.36% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| PGEN | Delayed | |
CBOE
| PGEN | Real-time | |
|
Tradegate
| I5X | Real-time | |
|
Berne S.E.
| I5X | End-of-day quote | |
|
Deutsche Boerse AG
| I5X | Delayed | |
|
Börse Stuttgart
| I5X | Delayed | |
|
Boerse Muenchen
| I5X | Real-time |
Last Transcript: Precigen, Inc.
| 1 day | -0.41% | ||
| 1 week | -7.35% | ||
| Current month | -28.56% | ||
| 1 month | -21.70% | ||
| 3 months | +10.58% | ||
| 6 months | +52.11% | ||
| Current year | +46.29% |
| 1 week | 5.96 |  | 6.63 |
| 1 month | 5.96 | | 8.98 |
| Current year | 3.04 | | 8.98 |
| 1 year | 3.04 | | 8.98 |
| 3 years | 0.65 | | 8.98 |
| 5 years | 0.65 | | 8.98 |
| 10 years | 0.65 | | 32.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Helen Sabzevari
CEO | Chief Executive Officer | 64 | 01/01/2020 |
Harry Thomasian
DFI | Director of Finance/CFO | 64 | 01/10/2021 |
Amy Lankford
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Randal Kirk
CHM | Chairman | 72 | 01/02/2008 |
Cesar Alvarez
BRD | Director/Board Member | 78 | 01/02/2008 |
Jeffrey Kindler
BRD | Director/Board Member | 70 | 28/11/2011 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 23/09/26 | Exercice | Chief Financial Officer | 1,07,330 | 0.0360% | ||
| 26/08/26 | Sell | Director | -1,85,000 | 0.0620% | ||
| 25/08/26 | Exercice | Executive/Senior Manager | 2,37,498 | 0.0796% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.41% | -7.35% | +50.62% | +471.50% | 220.19Cr | |
| +0.53% | +1.34% | +57.02% | +127.63% | 1,14300Cr | |
| +0.81% | +4.90% | +44.66% | +83.91% | 65TCr | |
| +0.40% | +0.90% | +26.29% | +102.53% | 51TCr | |
| -0.05% | +1.73% | +52.74% | +65.27% | 38TCr | |
| -0.87% | -6.08% | +61.74% | +37.09% | 35TCr | |
| +0.34% | +1.84% | +30.70% | +52.69% | 29TCr | |
| -0.45% | +1.19% | +2.89% | +24.92% | 26TCr | |
| +0.47% | +2.61% | +53.98% | +70.89% | 24TCr | |
| +0.37% | +3.75% | +35.16% | +104.87% | 20TCr | |
| Average | +0.12% | -0.24% | +41.58% | +114.13% | 40.3TCr | |
| Weighted average by Cap. | +0.29% | +0.70% | +44.45% | +87.11% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 24Cr 21Cr 20Cr 18Cr 33Cr 2.25TCr 33Cr 233.89Cr 93Cr 1.18TCr 88Cr 87Cr 3.73TCr | 44Cr 39Cr 36Cr 33Cr 61Cr 4.16TCr 62Cr 433.49Cr 172.66Cr 2.18TCr 164.02Cr 160.56Cr 6.92TCr |
| Net income | 8.35Cr 7.49Cr 6.92Cr 6.27Cr 12Cr 794.91Cr 12Cr 83Cr 33Cr 415.96Cr 31Cr 31Cr 1.32TCr | 24Cr 22Cr 20Cr 18Cr 34Cr 2.28TCr 34Cr 237.86Cr 95Cr 1.2TCr 90Cr 88Cr 3.79TCr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/26/28 | $6.085 | -1.06% | 16,30,852 |
| 27/26/27 | $6.150 | +1.82% | 37,90,136 |
| 26/26/26 | $6.040 | -2.42% | 25,47,296 |
| 23/26/23 | $6.190 | -3.13% | 43,47,284 |
| 22/26/22 | $6.390 | -3.18% | 62,53,831 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PGEN Stock
Select your edition
All financial news and data tailored to specific country editions
